Delivery Order 36F79720D0136-36C26224F0094
Award Date
11/8/23
Potential Completion Date
12/7/23
Potential Value
$46K
Federal Agency
Veterans Integrated Service Network 22
Awardee
Ferring Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Carrollton, TX 75010, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $45,829.15, was issued by the Department of Veterans Affairs (VA) to Ferring Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods. The award is a delivery order against Ferring's multiple-award indefinite-delivery vehicle (IDV) on the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), valued at $98.2 million over five years. Through this contract, Ferring will provide the VA with Adstiladrin (nadofaragene firadenovec), a...
Ferring Pharmaceuticals Inc. has received a $45,829.15 delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 to supply the oncology medication Nadofaragene Firadenovec, trade name Adstiladrin, for delivery to a location in Carrollton, Texas by March 30, 2024. This delivery order was issued against Ferring's existing Pharmaceuticals and Drugs Federal Supply Schedule contract with the VA, which has a potential value of $98.2...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awarded a $91,658.30 firm fixed price delivery order against the Pharmaceuticals and Drugs GSA Schedule to Ferring Pharmaceuticals Inc. for the provision of Nadofaragene Firadenovec, also known as Adstiladrin, to be delivered between November 13 and December 13, 2023 at the prime contractor's location in Parsippany, New Jersey. As the lead agency for providing healthcare services to...
This is a delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Ferring Pharmaceuticals Inc., a for-profit pharmaceutical manufacturer, for the provision of the bladder cancer drug Adstiladrin (nadofaragene firadenovec). The $274,974.90 firm-fixed-price order was placed against Ferring's existing multiple-award indefinite-delivery vehicle (IDV) on the VA's Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs, which has a total potential value of $98.2 million...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded Ferring Pharmaceuticals Inc. a $45,829.15 firm fixed price delivery order against the company's GSA Schedule Pharmaceuticals and Drugs contract. The order is for the delivery of NADOFARAGENE FIRADENOVEC-VNCG SUSP,INTRAVESICAL to locations in Parsippany, New Jersey between December 2023 and April 2024. No subcontractors or set aside designations were identified. This award will provide...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $15,090.88 delivery order to Janssen Biotech, Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB) for BALVERSA 4 MG. The firm fixed price order is for the delivery of the specified pharmaceutical product to a location in Carrollton, Texas, with performance to be completed by November 13, 2020. No set-aside designation was applied to this order placed...
The Department of Veterans Affairs (VA) awarded a $2,425.46 firm-fixed price delivery order to Vifor (International) AG, a global biotechnology company and manufacturer, to provide the pharmaceutical product Korsuva (difelikefalin) to VA facilities. This order was placed against Vifor's Federal Supply Schedule contract for Pharmaceuticals and Drugs. The delivery order has a completion date of May 8, 2024 and was awarded on April 23, 2024 without any set-aside designation. Vifor has previously...
The Department of Veterans Affairs Veterans Health Administration awarded a $11,283.90 delivery order against Travere Therapeutics, Inc.'s Pharmaceuticals and Drugs GSA Schedule contract (FSS-61-IB) to provide FILSPARI 200 MG. As part of VHA's mission to provide healthcare services to veterans, this contract will supply the drug from Travere Therapeutics' Bartlett, Tennessee division to VHA's Veterans Integrated Service Network 5 facilities. With a period of performance from December 13-19,...
The Department of Veterans Affairs Veterans Health Administration awarded a $678,720 delivery order to Emergent Devices Inc. under the company's Pharmaceuticals and Drugs Federal Supply Schedule contract. The order calls for Emergent Devices to supply pharmaceutical items to meet the clinical needs of VA's Veterans Integrated Service Network 12, located in Wayne, Pennsylvania, with performance from December 4-11, 2020. No subcontractors or set aside designations were identified. This order...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $1,212.73 firm-fixed price delivery order to Vifor (International) AG, a global biotechnology company, to supply DIFELIKEFALIN 50MCG/ML INJ,SOLN VIAL,1.3ML (KORSUVA) pharmaceuticals to VA facilities in Redwood City, CA. This order was placed under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. Vifor has also received previous awards from the VA, including a $23.8 million Blanket...